Ident. | Authors (with country if any) | Title |
---|
000629 |
J. F. Murray [États-Unis] | Pulmonary complications of HIV-1 infection among adults living in sub-Saharan Africa |
000650 |
Rita F. Helfand [États-Unis] ; William J. Moss [États-Unis] ; Rafael Harpaz [États-Unis] ; Susana Scott [Royaume-Uni] ; Felicity Cutts [Gambie] | Evaluating the impact of the HIV pandemic on measles control and elimination |
000708 |
Charles B. Holmes [États-Unis] ; Elena Losina [États-Unis] ; Rochelle P. Walensky [États-Unis] ; Yazdan Yazdanpanah [France] ; Kenneth A. Freedberg [États-Unis] | Review of human immunodeficiency virus type 1-related opportunistic infections in Sub-Saharan Africa |
000742 |
Alwyn Mwinga [Zambie] ; Maria Hosp [Zambie] ; Isaac Zulu [Zambie, Royaume-Uni] ; Michael J. G. Farthing [Royaume-Uni] ; Sylvia Mulambo [Zambie] ; Paul Kelly [Zambie, Royaume-Uni] | Tuberculosis preventative treatment also prevented diarrhoea in HIV-infected patients in Zambia |
000755 |
Paul Kelly [Zambie, Royaume-Uni] ; Isaac Zulu [Zambie, Royaume-Uni] ; Beatrice Amadi [Zambie] ; Mwansa Munkanta [Zambie] ; Jacqueline Banda [Zambie] ; Laura C. Rodrigues [Royaume-Uni] ; David Mabey [Royaume-Uni] ; Roger Feldman [Royaume-Uni] ; Michael J. G. Farthing [Royaume-Uni] | Morbidity and nutritional impairment in relation to CD4 count in a Zambian population with high HIV prevalence |
000798 |
A. M. Veitch [Royaume-Uni] ; P. Kelly [Royaume-Uni] ; I. Zulu [Royaume-Uni] ; T. T. Macdonald [Zambie] ; M. J. G. Farthing [Royaume-Uni] | Lack of evidence for small intestinal mucosal T-cell activation as a pathogenic mechanism in african HIV-associated enteropathy |
000824 |
P. Mwaba [Zambie] ; J. Mwansa [Zambie] ; C. Chintu [Zambie] ; J. Pobee [Zambie] ; M. Scarborough [Royaume-Uni] ; S. Portsmouth [Royaume-Uni] ; A. Zumla [Zambie, Royaume-Uni] | Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions |
000825 |
Richard D. Waddell [États-Unis] ; Kennedy Lishimpi [Zambie] ; C. Fordham Von Reyn [États-Unis] ; Chifumbe Chintu [Zambie] ; K. S. Baboo [Zambie] ; Barry Kreiswirth [États-Unis] ; Elizabeth A. Talbot [États-Unis] ; Margaret R. Karagas [États-Unis] | Bacteremia due to Mycobacterium tuberculosis or M. bovis, Bacille Calmette-Guérin (BCG) among HIV-positive children and adults in Zambia |
000826 |
Jaiyeola O. Thomas [Nigeria] | Acquired immunodeficiency syndrome-associated cancers in Sub-Saharan Africa |
000880 |
R. D. Waddell [États-Unis] ; C. F. Von Reyn [États-Unis] ; K. S. Baboo [Zambie] ; A. Mwinga [Zambie] ; C. Chintu [Zambie] ; A. Zumla [Royaume-Uni] | The effects of BCG immunization and human immunodeficiency virus infection on dual skin test reactions to purified protein derivative and Mycobacterium avium sensitin among adults in Zambia |
000881 |
S. D. Lawn [États-Unis, Royaume-Uni] ; R. J. Shattock [Royaume-Uni] ; J. W. Acheampong [Ghana] ; R. B. Lal [États-Unis] ; T. M. Folks [États-Unis] ; G. E. Griffin [Royaume-Uni] ; S. T. Butera [États-Unis] | Sustained plasma TNF-α and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans |
000883 |
P. Godfrey-Faussett [Royaume-Uni] ; M. Quigley [Royaume-Uni] ; H. Ayles [Royaume-Uni, Zambie] ; AIWYN MWINGA [Zambie] ; M. Hosp [Royaume-Uni] ; J. Porter [Royaume-Uni] | Screening people living with HIV before tuberculosis preventative therapy |
000885 |
P. Kelly [Royaume-Uni] ; R. Musonda ; E. Kafwembe ; L. Kaetano ; E. Keane ; M. Farthing [Royaume-Uni] | Micronutrient supplementation in the AIDS diarrhoea-wasting syndrome in Zambia : A randomized controlled trial |
000886 |
S. Gregson [Royaume-Uni] ; B. Zaba [Royaume-Uni] ; G. P. Garnett [Royaume-Uni] | Low fertility in women with HIV and the impact of the epidemic on orphanhood and early childhood mortality in sub-Saharan Africa |
000887 |
H. C. Bucher [Suisse] ; L. E. Griffith [Canada] ; G. H. Guyatt [Canada] ; P. Sudre [Suisse] ; M. Naef [Suisse] ; P. Sendi [Suisse] ; M. Battegay [Suisse] | Isoniazid prophylaxis for tuberculosis in HIV infection : a meta-analysis of randomized controlled trials |
000904 |
F. Amon-Tanohdick [Côte d'Ivoire] ; K. Domoua [Côte d'Ivoire] ; A. M. N'Goan-Domoua [Côte d'Ivoire] ; P. Msellati [Côte d'Ivoire] | Etiologies des complications pulmonaires du SIDA pédiatrique en Afrique sub-saharienne |
000905 |
A. Mwinga [Zambie, Royaume-Uni] ; M. Hosp [Zambie, Royaume-Uni] ; P. Godfrey-Faussett [Zambie, Royaume-Uni] ; M. Quigley [Royaume-Uni] ; P. Mwaba [Zambie] ; B. N. Mugala [Zambie] ; O. Nyirenda [Zambie] ; N. Luo [Zambie] ; J. Pobee [Zambie] ; A. M. Elliott [Zambie, Royaume-Uni] ; K. P. W. J. Mcadam [Royaume-Uni] ; J. D. H. Porter [Royaume-Uni] | Twice weekly tuberculosis preventive therapy in HIV infection in Zambia |
000924 |
S. Nath [Zambie] ; G. Jovic [Zambie] | Cancrum oris : Management, incidence, and implications of human immunodeficiency virus in Zambia |
000948 |
P. Kelly [Royaume-Uni] ; S. E. Davies [Royaume-Uni] ; B. Mandanda [Zambie] ; A. Veitch [Royaume-Uni] ; G. Mcphail [Royaume-Uni] ; I. Zulu [Zambie] ; F. Drobniewski [Royaume-Uni] ; D. Fuchs [Autriche] ; C. Summerbell [Royaume-Uni] ; N. P. Luo [Zambie] ; J. O. M. Pobee [Zambie] ; M. J. G. Farthing [Royaume-Uni] | Enteropathy in Zambians with HIV related diarrhoea : regression modelling of potential determinants of mucosal damage |
000973 |
P. Kelly [Zimbabwe] ; F. Lungu [Zimbabwe] ; E. Keane ; R. Baggaley ; F. Kazembe [Zimbabwe] ; J. Pobee [Zimbabwe] ; M. Farthing | Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia : a randomised double blind controlled trial |
000986 |
N. T. Cheung [Royaume-Uni] ; J. Saklatvala ; P. T. Dawes | Multiple joint avascular necrosis : beware of tuberculosis and human immunodeficiency virus : a rare but important cause |
000997 |
M. P. Shilalukey-Ngoma [Zambie] | HIV/SIDA néonatal en Zambie. L'expérience d'une décade: 1982-1992 |
000A24 |
G. Desai [Zambie] | A bilharzioma in association with HIV disease |